|
Biopolitics in 2023
CGS Staff, Biopolitical Times | 01.08.2024
In 2023, CGS stepped up its efforts to put social justice and human rights at the center of discussions about powerful new human biotechnologies, from challenging the international gene editing summit to scrutinizing “hipster eugenics” and developments in AI.
| |
|
2023 was a big year for CRISPR-based gene editing but challenges remain
Malak Saleh, Endgadget | 12.20.2023
Discussing the FDA’s approval of the sickle cell gene therapy treatment Casgevy late last year, CGS’ Katie Hasson commented, “It's not just about who gets access to the medication once it comes on the market but really how can we prioritize equity in the research that's leading to these treatments.”
| |
GENE EDITING | EUGENICS | ASSISTED REPRODUCTION
SURROGACY360 | VARIOUS
| |
Genotoxic Effects of Base and Prime Editing
Kamal Nahas, The Scientist | 01.12.2024
A risk-benefit analysis of gene editing tools in stem cells revealed that base and prime editing carry “genotoxic effects” similar to those of CRISPR-Cas9, but at a reduced rate.
| |
How CRISPR could yield the next blockbuster crop
Michael Marshall, Nature | 01.09.2024
Researchers are trying to “domesticate” crops like rice using CRISPR, but there are issues with the technical aspects of the approach and concerns about exploitation of Indigenous communities’ knowledge.
| |
Gene Editing Needs to Be for Everyone
Jennifer Doudna, Wired | 01.08.2024
2023 brought the first-ever FDA approval of a CRISPR gene therapy – a major milestone in gene editing treatments. But more work is needed to make cutting-edge gene therapies accessible and equitable.
| |
Trump echoes Hitler — and MAGA hears it loud and clear
Heather Digby Parton, Salon | 12.18.2023
Trump’s recent campaign speeches echoing Hitler further confirm his support of eugenics. Even more disturbing, the response he gets from his tens of millions of followers clearly shows that they share it.
| |
Scientists call for review of UK’s 14-day rule on embryo research
Hannah Devlin, The Guardian | 12.30.2023
Some scientists want to overhaul the 14-day rule on human embryo research to gain knowledge on miscarriage and congenital conditions. Others are skeptical of the insights those scientists claim are in store if the limit were to be lifted.
| |
|
Irish LGBTQ+ organisations respond to Pope's call to ban surrogacy
Nicole Lee, Yahoo News | 01.09.2024
In a recent address, Pope Francis advocated for a worldwide ban on surrogacy arrangements. LGBTQ activists in Ireland objected to the Pope’s stance and reiterated their support for legislation to protect all involved in surrogacy arrangements.
|
|
Cloned rhesus monkey created to speed medical research
Pallab Ghosh, BBC | 01.16.2024
Chinese researchers have cloned the first rhesus monkey with the aim of speeding up testing of drugs for humans, but many question whether animal suffering in the cloning experimentation process is justified.
| |
ChatGPT Helps, and Worries, Business Consultants, Study Finds
David Berreby, The New York Times | 12.28.2023
Researchers’ tests of AI for business consulting work showed that ChatGPT did help perform some creative tasks. But its analysis of data and transcripts was often inaccurate, and workers were uneasy about using it.
| |
Cory Doctorow: What Kind of Bubble is AI?
Cory Doctorow, Locus | 12.18.2023
Massive investment in AI startups have shown few promising long-term gains. The AI bubble, like every bubble, will pop eventually. When it inevitably does, what will be left behind?
| | | | |